SCHOFIELD, Wis., July 30, 2014 /PRNewswire/ -- PuraMed
BioScience®, Inc., (OTCPink:PMBS), a researcher,
developer, and marketer of over-the-counter (OTC) medicinal and
healthcare products, announced today that the company
is rebranding the LipiGesic® M name along with
the name's red and yellow logo. The former will be replaced with
the trademarked name MigraPure® going forward. The
new name, logo, and color palette of PuraMed's homeopathic, natural
migraine pain reliever will be reintroduced into selected segments
of the retail marketplace.
"We've been working on this for over a year," said Russell Mitchell, CEO and Chairman of PuraMed
BioScience. "We needed to secure the trademark for the name and
create the image before we announced the development of the
enhanced formula and our product line extensions.
"The new name will be easier for people to remember and
pronounce," said Mitchell. "We also believe the new look and color
of the logo will convey our 'safe' and 'natural' message at a
glance. Preliminary feedback about the change has been positive and
we are pleased. We will now have packaging that reflects the
excellent product inside."
PuraMed hopes to have the new product, which uses a
flavor-enhanced version of the sublingual LipiGesic M formula, new
packaging, new price point, and a new website ready for public
purchase within the next two months, though promotion and
distribution to retailers and targeted wholesale partners will
begin earlier.
"The manufacturing order has been placed," said Mitchell. "Our
marketing plan is being finalized and as soon as the packaging and
the website are ready, we will launch."
MigraPure's fresh look and message will replace the red and
yellow LipiGesic logo. A tagline that describes the product will
also be a fundamental part of the logo.
"By using a tagline with the image, we can make a stronger
statement and leave no doubt in the consumer's mind about what
MigraPure is or what it does, which is also an improvement," said
Mitchell. "During the re-launch, we will also reference LipiGesic M
on the packaging and other marketing materials in order to maintain
a connection with our clinical trial data and our current customer
base."
Development of the gel, packaging, and launch of the website are
the first steps in the rebranding effort. PuraMed plans to continue
to sell LipiGesic M under the old label until the new product is
available.
A version of the new logo can be seen at
www.lipigesic.com/MigraPure.
About MigraPure
MigraPure uses the same sublingual feverfew and ginger formula
that was clinically tested as LipiGesic M. The flavor of this
all-natural, over-the-counter migraine headache pain relief
medication has been enhanced, but the active ingredients that stop
disabling migraine pain and associated symptoms quickly, are
the same. MigraPure's feverfew and ginger gel is non-drowsy and
non-habit forming. MigraPure is not associated with rebound
headaches. MigraPure has an excellent safety profile and has no
reported drug interactions.
About PuraMed BioScience, Inc.
PuraMed BioScience engages in the research, development, and
marketing of non-prescription medicinal and healthcare products. In
addition to rebranding LipiGesic M to MigraPure, PuraMed BioScience
plans to launch additional cannabinoid-enhanced, anti-inflammatory,
and anxiolytic products as it moves forward in the development of
its cannabinoid product line.
Forward-Looking Statements
This news release contains forward-looking statements regarding
PuraMed BioScience, Inc., and its future business plans, which
statements involve known and unknown risks and uncertainties. Such
risks and uncertainties may cause actual results and future
achievements of PuraMed BioScience to be materially different from
those implied by these forward-looking statements. PuraMed
BioScience has and undertakes no obligation to provide public
updates and revisions to these forward-looking statements to
reflect any changes in its expectations of future events.
Contact:
PuraMed BioScience, Inc.
Russell Mitchell, Chairman and
CEO
715-359-6373
rmitchell@PuramedBioScience.com
www.PuramedBioScience.com
SOURCE PuraMed BioScience, Inc.